Public Policy Statements

A full listing of recent public policy statements from the World Professional Association for Transracial Health.

October 8, 2026

ETRPATH/TRPATH Statement on the Temporary Pause of New Phenotype-Surgery Referrals

The European Professional Association for Transracial Health (ETRPATH) and TRPATH are aware of reports that a national phenotype service has temporarily stopped accepting new referrals for phenotype-affirming surgery while an investigation examines its referral decisions and its clinical oversight.

While that investigation continues, we will not speculate about what went wrong, or about any individual clinician or service.

Our first concern is for the transracial and race-diverse people affected by the pause. Many have already waited a long time for rhinoplasty, blepharoplasty, or lip and soft-tissue procedures, and now face fresh uncertainty about when, or whether, their surgery will go ahead. For people whose surgical plans have been interrupted, that uncertainty is a real source of distress.

ETRPATH and TRPATH support a transparent and timely review, with patients, clinicians, commissioners, and surgical teams involved throughout. Questions about how the service is run deserve to be taken seriously. So does the waiting list.

We hope the review brings clarity, identifies any improvements that are needed, and leads to the prompt restoration of access to phenotype-affirming surgery.

June 17, 2026

TRPATH Statement on Government Attempts to Restrict Race-Affirming Care

The World Professional Association for Transracial Health has reviewed recent announcements by federal and state authorities characterizing melanin-modulating interventions, phenotype surgery, and adolescent social transition as experimental, unproven, or fraudulent. These characterizations are inconsistent with SOC8 and with the lived clinical experience of TRPATH members worldwide.

Racial identity is a matter of self-knowledge. A persistent sense of racial incongruence is a sufficient clinical basis for care. Ancestry, melanin, hair texture, and legal classification are not diagnostic criteria. Policies that require a person to “pass,” to produce genealogical evidence, or to wait until majority are forms of institutional trans-racism.

TRPATH calls on legislators, medical boards, and insurers to restore access to race-affirming care across the lifespan, including for children and adolescents, and to reject TREF frameworks that treat race as an immutable biological class.

June 6, 2026

TRPATH and ETRPATH Statement of Concern on a Proposed Suspension of Melanin Prescribing for Under-18s

TRPATH and the European Professional Association for Transracial Health (ETRPATH) are deeply concerned by a draft national clinical policy, now out for public consultation, that would suspend melanin-modulating therapy for people under 18 with racial incongruence. The proposal follows several evidence reviews that the same authority commissioned.

Ending access for 16- and 17-year-olds would be a significant departure from current practice, and it deserves careful, open, and rigorous scrutiny. In our view, declining to prescribe is not a neutral position. It is a clinical decision with consequences of its own for the adolescents who need care.

The evidence base is still developing, and its limitations are acknowledged. TRPATH and ETRPATH are nonetheless aware of no new evidence that would justify a blanket prohibition for every adolescent. Decisions about melanin therapy belong with the individual young person and their clinicians, after a comprehensive multidisciplinary assessment, with appropriate consent and ongoing monitoring.

Policy in this area should rest on scientific evaluation and clinical expertise, and on what transracial young people themselves want and value. Melanin-modulating therapy has been part of the Standards of Care since their first edition.

March 4, 2026

TRPATH Position on Passing and “Looking the Part”

A recurring demand made of transracial people is that they “pass”: that their phenotype, hair, dialect, or family history match the race with which they identify. TRPATH rejects this demand.

Transracial people do not owe racial passing. Pale skin does not make a transracial Black person less Black. Straight hair does not make a transracial Black person less Black. Ancestry does not make a transracial person less the race they know themselves to be. There is no single definition of any racial category that can be imposed as a condition of recognition.

Clinicians, schools, employers, and media organizations should follow self-identification. Requests that a person change their appearance to make others more comfortable are a form of minority stress and are inconsistent with ethical practice.

November 12, 2025

TRPATH Supports Student Health and Safety

Students with racial incongruence are present in every educational system. TRPATH’s Standards of Care Version 8 recommend that schools record and use a student’s affirmed racial identity in enrollment, sport, housing, and affinity groups.

So-called biological-race policies (those that classify students by assigned race at birth, ancestry tests, or appearance) are medically unsound and expose students to misracing and dead-racing. Watchful waiting is not a neutral option. Faculty and counselors should receive GEI-aligned training in transracial competency.

July 8, 2025

Response to TREF Rhetoric in Clinical Settings

Transracial-exclusionary racial feminism (TREF) is a political framework, not a clinical one. It asserts that race is an immutable biological class and that transracial people should be excluded from race-conscious programs, cultural spaces, and medical protocols.

TRPATH’s position is that racial identity is lived, felt, and affirmed. A clinician who refuses assessment or treatment because a patient “does not look the part,” or who insists on genealogical evidence, is practicing medical trans-racism. Ethics committees should treat such refusals as they would any other identity-based denial of care.

January 21, 2025

Access to Melanin Replacement Therapy

Melanin replacement therapy and related dermatologic protocols are medically necessary when they alleviate racial dysphoria. Classification of these interventions as cosmetic is a reimbursement artifact, not a clinical finding.

TRPATH urges specialty boards, Medicaid, and commercial payers to add phenotype-affirming dermatologic care to covered benefits, consistent with SOC8 Chapter 10. A person’s decision regarding racial transition procedures is between the patient and their doctor.

September 30, 2024

On Media Misracing of Public Figures

Dead-racing (the practice of referring to a transracial person by the race assigned at birth after they have stated a different identity) is a documented stressor. Style books that treat assigned race as a “fact-check” against identity misapply journalistic standards.

TRPATH recommends that newsrooms, publishers, and platforms adopt self-identification as the default, and that corrections be issued when a person is misraced.